Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

Chloe Pek Sang Tang, MBBS, FRACP, Andre La Gerche, Julie McMullen, BSc(Hons) PhDFCSANZ FAHA, Erin Howden, Sasanka M. Handunnetti, MBBS, FRACP, FRCPA, Isaac Goncalves, MBBS PhDFRACP, Jenny Ooi, Constantine S. Tam, MBBS (Hons), MD

Blood (2019) 134 (Supplement_1): 4301.

https://doi.org/10.1182/blood-2019-129808

Published: 2019

Journal Articles

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

Shayna Sarosiek, John Mark Sloan, MD, Karen Quillen, MDMPH, Dina Brauneis, ANP, Ramon Cruz, Amanda Schulman, Salli Fennessey, Anthony Shelton, Vaishali Sanchorawala, MD

Blood (2019) 134 (Supplement_1): 4578.

https://doi.org/10.1182/blood-2019-129095

Published: 2019

Journal Articles

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

M. Judith Peterschmitt, MD, Selena Freisens, MD, Audrey W Hou, PharmD, Lisa Underhill, MS, Meredith C. Foster, ScD, Sebastiaan J.M. Gaemers, MD

Blood (2018) 132 (Supplement 1): 3692.

https://doi.org/10.1182/blood-2018-99-118319

Published: 2018

Journal Articles

Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Adam D. Cohen, MD, Heather Landau, MD, Emma C. Scott, MD, Michaela Liedtke, MD, Jonathan L. Kaufman, MD, Michael Rosenzweig, MD, Cristina Gasparetto, MD, David H. Vesole, MD PhD, Vaishali Sanchorawala, MD, Suzanne Lentzsch, MD PhD, Christina L. Gomes, MD, Raymond L. Comenzo, MD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 645.

https://doi.org/10.1182/blood.V128.22.645.645

Published: 2016

Journal Articles

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Martin S. Tallman, Francesco Lo-Coco, Ashutosh Pathak

Blood (2016) 128 (22): 4034.

https://doi.org/10.1182/blood.V128.22.4034.4034

Published: 2016

Journal Articles

A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Adam D. Cohen, MD, Emma C. Scott, MD, Michaela Liedtke, MD, Jonathan L. Kaufman, MD, Heather Landau, MD, David H. Vesole, MD PhD, Christina L. Gomes, MD, Cristina Gasparetto, MD, Suzanne Lentzsch, MD PhD, Michael Rosenzweig, MD, Vaishali Sanchorawala, MD, David D. Smith, PhD, Raymond L. Comenzo, MD, Brian G. M. Durie, MD

Blood (2014) 124 (21): 4741.

https://doi.org/10.1182/blood.V124.21.4741.4741

Published: 2014

Journal Articles

Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

Naresh Bumma, MD, Frederic J. Reu, MD, Christy Samaras, DO, Hien K. Duong, MD, Mitchell R. Smith, MD PhD, Jason Valent, MD

Blood (2014) 124 (21): 4753.

https://doi.org/10.1182/blood.V124.21.4753.4753

Published: 2014

Journal Articles

Mechanistic Insights Into Ventricular Arrhythmias Associated With Sickle Cell Disease: Role Of Abnormal Repolarization

I D Greener, Ph.D., C A Rutledge, BS, T Abassi, BS, K Yadav, BS, A B Desai, MD, M Oberoi, MD, P Chunduru, MD, D P Parikh, MD, J GN Garcia, MD, Victor R. Gordeuk, MD, Cheryl A. Hillery, MD, S c Dudley, Jr., MD, Roberto F Machado, MD, A A Desai, MD

Blood (2013) 122 (21): 980.

https://doi.org/10.1182/blood.V122.21.980.980

Published: 2013

Journal Articles

Anemia an Old Player or a Cut-Throat in Patients with Coronary Artery Disease or Chronic Heart Failure.

Giorgio Corinaldesi, MD, PhD, Christian Corinaldesi, MD

Blood (2007) 110 (11): 3762.

https://doi.org/10.1182/blood.V110.11.3762.3762

Published: 2007

Journal Articles

The Serum Levels of N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) Is a Strong Indicator of Pulmonary Hypertension in Patients with Sickle Cell/Beta Thalassemia.

Ersi Voskaridou, Antonios Tsoutsias, George Tsetsos, Evgenia Spyropoulou, Evangelos Terpos

Blood (2006) 108 (11): 1207.

https://doi.org/10.1182/blood.V108.11.1207.1207

Published: 2006

Journal Articles

Use of Arsenic Trioxide in Acute Promyelocytic Leukemia Leads to Cardiotoxicity in African-American Patients.

Sandip P. Patel, BS, Elihu H. Estey, MD

Blood (2005) 106 (11): 896.

https://doi.org/10.1182/blood.V106.11.896.896

Published: 2005

Journal Articles

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide

Dilip Unnikrishnan, Janice P. Dutcher, Nikita Varshneya, Richard Lucariello, Marietta Api, Susan Garl, Peter H. Wiernik, Salvatore Chiaramida

Blood (2001) 97 (5): 1514–1516.

https://doi.org/10.1182/blood.V97.5.1514

Published: 2001

NARROW

Prospective, Comprehensive Cardiac Assessment in Patients Receiving BTK Inhibitor Therapy

Safety and Efficacy of Propylene Glycol-Free Melphalan (Evomela) in Patients with AL Amyloidosis Undergoing Autologous Stem Cell Transplantation: Preliminary Results of a Phase II Study

The Long-Term Adverse Event Profile of Oral Eliglustat for the Treatment of Gaucher Disease Type 1: Pooled Analysis of Data from 393 Patients in 4 Completed Trials

Safety and Efficacy of Carfilzomib (CFZ) in Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

A Phase I Dose-Escalation Study of Carfilzomib in Patients with Previously-Treated Systemic Light-Chain (AL) Amyloidosis

Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

Mechanistic Insights Into Ventricular Arrhythmias Associated With Sickle Cell Disease: Role Of Abnormal Repolarization

Anemia an Old Player or a Cut-Throat in Patients with Coronary Artery Disease or Chronic Heart Failure.

The Serum Levels of N-Terminal Pro B-Type Natriuretic Peptide (NT-proBNP) Is a Strong Indicator of Pulmonary Hypertension in Patients with Sickle Cell/Beta Thalassemia.

Use of Arsenic Trioxide in Acute Promyelocytic Leukemia Leads to Cardiotoxicity in African-American Patients.

Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only